Trial Profile
A correlative study of Nabiximols therapy and neurophysiological parameters, walking performance tests and self-reported questionnaires in patients with multiple sclerosis spasticity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Sep 2016
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 14 Sep 2016 New trial record